Evidence has been mounting that anti-malarial drug hydroxychloroquine isn't effective - and may even be dangerous. Now the UN's World Health Organization has paused its trial of the drug. It cited a major study published in last week, which found that hydroxy-chloroquine could lead to arrhythmias - abnormal heart beats - and worsen Covid patients' survival chances. The WHO had already expressed skepticism about hydroxychloroquine. Now it has announced it'll stop its own trial of the drug while it further reviews the drug's safety.
Tuesday, May 26, 2020
WHO pauses hydroxychloroquine trial German government bails out Lufthansa
Evidence has been mounting that anti-malarial drug hydroxychloroquine isn't effective - and may even be dangerous. Now the UN's World Health Organization has paused its trial of the drug. It cited a major study published in last week, which found that hydroxy-chloroquine could lead to arrhythmias - abnormal heart beats - and worsen Covid patients' survival chances. The WHO had already expressed skepticism about hydroxychloroquine. Now it has announced it'll stop its own trial of the drug while it further reviews the drug's safety.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment